Expression and Detection of the MMP-2 Protein in the Eye
Run Jiang1, 2, Jibo Zhou1, 2
1 Department of Ophthalmology, Ninth People's Hospital, Shanghai JiaoTong University School of Medicine, Shanghai 200011, China 2 Shanghai Key Laboratory of Orbital Diseases and Ocular Oncology, Shanghai 200011, China
Abstract: Matrix metalloproteinase-2 (MMP-2) is one of the matrix metalloproteinase proteins. Its abnormal expression has been proven to be related to the occurrence and development of various ophthalmic diseases in recent years. We summarize the expression and detection of MMP-2 in the eye and the effects of MMP-2 in ophthalmic diseases.
蒋润1,2 周激波1,2. MMP-2在眼组织中的表达与检测[J]. 中华眼视光学与视觉科学杂志, 2021, 23(4): 312-316.
Run Jiang1, 2, Jibo Zhou1, 2. Expression and Detection of the MMP-2 Protein in the Eye. Chinese Journal of Optometry Ophthalmology and Visual science, 2021, 23(4): 312-316. DOI: 10.3760/cma.j.cn115909-20191230-00356
Murphy GJ, Murphy G, Reynolds JJ. The origin of matrix metalloproteinases and their familial relationships. FEBS Lett, 1991, 289(1): 4-7. DOI: 10.1016/0014-5793(91)80895-a.
[2]
Butler GS, Overall CM. Updated biological roles for matrix metalloproteinases and new "intracellular" substrates revealed by degradomics. Biochemistry, 2009, 48(46): 10830-10845. DOI: 10.1021/bi901656f.
[3]
Young D, Das N, Anowai A, et al. Matrix metalloproteases as influencers of the cells' social media. Int J Mol Sci, 2019, 20(16): 3847. DOI: 10.3390/ijms20163847.
[4]
Hendrix AY, Kheradmand F. The role of matrix metalloproteinases in development, repair, and destruction of the lungs. Prog Mol Biol Transl Sci, 2017, 148: 1-29. DOI: 10.1016/bs.pmbts.2017.04.004.
[5]
Li X, Qu L, Zhong Y, et al. Association between promoters polymorphisms of matrix metalloproteinases and risk of digestive cancers: A meta-analysis. J Cancer Res Clin Oncol, 2013, 139(9): 1433-1447. DOI: 10.1007/s00432-013-1446-9.
[6]
Doulamis IP, Tzani AI, Konstantopoulos PS, et al. A sirtuin 1/MMP2 prognostic index for myocardial infarction in patients with advanced coronary artery disease. Int J Cardiol, 2017, 230: 447-453. DOI: 10.1016/j.ijcard.2016.12.086.
[7]
Henriet P, Emonard H. Matrix metalloproteinase-2: Not (just) a "hero" of the past. Biochimie, 2019, 166: 223-232. DOI: 10.1016/j.biochi.2019.07.019.
Smith VA, Rishmawi H, Hussein H, et al. Tear film MMP accumulation and corneal disease. Br J Ophthalmol, 2001, 85(2): 147-153. DOI: 10.1136/bjo.85.2.147.
[10]
Balasubramanian SA, Mohan S, Pye DC, et al. Proteases, proteolysis and inflammatory molecules in the tears of people with keratoconus. Acta Ophthalmol, 2012, 90(4): e303-309. DOI: 10.1111/j.1755-3768.2011.02369.x.
[11]
Petznick A, Madigan MC, Garrett Q, et al. Contributions of ocular surface components to matrix-metalloproteinases (MMP)-2 and MMP-9 in feline tears following corneal epithelial wounding. PLoS One, 2013, 8(8): e71948. DOI: 10.1371/ journal.pone.0071948.
[12]
Jia Y, Hu D-N, Zhu D, et al. MMP-2, MMP-3, TIMP-1, TIMP-2, and TIMP-3 protein levels in human aqueous humor: relationship with axial length. Invest Ophthalmol Vis Sci, 2014, 55(6): 3922-3928. DOI: 10.1167/iovs.14-13983.
F i n i M E , Yu e B Y, S u g a r J . C o l l a g e n o l y t i c / gelatinolyticmetalloproteinases in normal and keratoconus corneas. Curr Eye Res, 1992, 11(9): 849-862. DOI: 10.3109/ 02713689209033483.
[15]
Zhou L, Sawaguchi S, Twining SS, et al. Expression of degradative enzymes and protease inhibitors in corneas with keratoconus. Invest Ophthalmol Vis Sci, 1998, 39(7): 1117- 1124.
[16]
Smith VA, Easty DL. Matrix metalloproteinase 2: involvement in keratoconus. Eur J Ophthalmol, 2000, 10(3): 215-226. DOI: 10.1177/112067210001000305.
Micera A, Quaranta L, Esposito G, et al. Differential Protein Expression Profiles in Glaucomatous Trabecular Meshwork: An Evaluation Study on a Small Primary Open Angle Glaucoma Population. Adv Ther, 2016, 33(2): 252-267. DOI: 10.1007/ s12325-016-0285-x.
[19]
Jiang Y, Zhang C, Ma J, et al. Expression of matrix Metalloproteinases-2 and aquaporin-1 in corneoscleral junction after angle-closure in rabbits. BMC Ophthalmol, 2019, 19(1): 43. DOI: 10.1186/s12886-019-1058-5.
[20]
Xi LY-Y, Yip SP, Shan SW, et al. Region-specific differential corneal and scleral mRNA expressions of MMP2, TIMP2, and TGFB2 in highly myopic-astigmatic chicks. Sci Rep, 2017, 7(1): 11423. DOI: 10.1038/s41598-017-08765-6.
[21]
Yang SR, Ye JJ, Long Q. Expressions of collagen, matrix metalloproteases-2, and tissue inhibitor of matrix metalloproteinase-2 in the posterior sclera of newborn guinea pigs with negative lens-defocused myopia. Zhongguo Yi Xue Ke Xue Yuan Xue Bao, 2010, 32(1): 55-59. DOI: 10.3881/ j.issn.1000-503X.2010.01.014.
[22]
Zhao F, Zhou Q, Reinach PS, et al. Cause and effect relationship between changes in scleral matrix metallopeptidase-2 expression and Myopia development in mice. Am J Pathol, 2018, 188(8): 1754-1767. DOI: 10.1016/j.ajpath.2018.04.011.
[23]
Li JH, Wang NL, Wang JJ. Expression of matrix metalloproteinasesof human lens epithelial cells in the cultured lens capsule bag. Eye (Lond), 2008, 22(3): 439-444. DOI: 10.1038/sj.eye.6702735.
Vaughan-Thomas A, Gilbert SJ, Duance VC. Elevated levels of proteolytic enzymes in the aging human vitreous. Invest Ophthalmol Vis Sci, 2000, 41(11): 3299-3304.
[26]
Zhuang H, Zhang R, Shu Q, et al. Changes of TGF-β2, MMP-2, and TIMP-2 levels in the vitreous of patients with high myopia. Graefes Arch Clin Exp Ophthalmol, 2014, 252(11): 1763-1767. DOI: 10.1007/s00417-014-2768-2.
Rathi S, Jalali S, Patnaik S, et al. Abnormal Complement Activation and Inflammation in the Pathogenesis of Retinopathy of Prematurity. Front Immunol, 2017, 8: 1868. DOI: 10.3389/ fimmu.2017.01868.
[29]
Hofmaier F, Hauck SM, Amann B, et al. Changes in Matrix Metalloproteinase Network in a Spontaneous Autoimmune Uveitis Model. Invest Ophthalmol Vis Sci, 2011, 52(5): 2314. DOI: 10.1167/iovs.10-6475.
Yang R, Liu H, Williams I, et al. Matrix metalloproteinase-2 expression and apoptogenic activity in retinal pericytes: implications in diabetic retinopathy. Ann N Y Acad Sci, 2007, 1103: 196-201. DOI: 10.1196/annals.1394.000.
Wang X, Hu Y, Cui J, et al. Coordinated targeting of MMP-2/ MMP-9 by miR-296-3p/FOXCUT exerts tumor-suppressing effects in choroidal malignant melanoma. Mol Cell Biochem, 2018, 445(1-2): 25-33. DOI: 10.1007/s11010-017-3248-x.
[36]
Yang S-F, Lin C-Y, Yang P-Y, et al. Increased expression of gelatinase (MMP-2 and MMP-9) in pterygia and pterygium fibroblasts with disease progression and activation of protein kinase C. Invest Ophthalmol Vis Sci, 2009, 50(10): 4588-4596. DOI: 10.1167/iovs.08-3147.
[37]
P a r k s W C , Wi l s o n C L , L ó p e z - B o a d o Y S . M a t r i x metalloproteinases as modulators of inflammation and innate immunity. Nat Rev Immunol, 2004, 4(8): 617-629. DOI: 10.1038/nri1418.
[38]
Sakimoto T, Sawa M. Metalloproteinases in corneal diseases: degradation and processing. Cornea, 2012, 31(Suppl 1): S50-56. DOI: 10.1097/ICO.0b013e318269ccd0.
Guggenheim JA, McBrien NA. Form-deprivation myopia induces activation of scleral matrix metalloproteinase-2 in tree shrew. Invest Ophthalmol Vis Sci, 1996, 37(7): 1380-1395.
[41]
Rada JA, Perry CA, Slover ML, et al. Gelatinase A and TIMP-2 expression in the fibrous sclera of myopic and recovering chick eyes. Invest Ophthalmol Vis Sci, 1999, 40(13): 3091-3099.
[42]
Rada JA, Brenza HL. Increased latent gelatinase activity in the sclera of visually deprived chicks. Invest Ophthalmol Vis Sci, 1995, 36(8): 1555-1565.
[43]
Schippert R, Brand C, Schaeffel F, et al. Changes in scleral MMP-2, TIMP-2 and TGFbeta-2 mRNA expression after imposed myopic and hyperopic defocus in chickens. Exp Eye Res, 2006, 82(4): 710-719. DOI: 10.1016/j.exer.2005.09.010.
[44]
Siegwart JT Jr, Norton TT. Selective regulation of MMP and TIMP mRNA levels in tree shrew sclera during minus lens compensation and recovery. Invest Ophthalmol Vis Sci, 2005, 46(10): 3484-3492. DOI: 10.1167/iovs.05-0194.
Ta k a h a s h i H , A k i b a K , N o g u c h i T, e t a l . M a t r i x metalloproteinase activity is enhanced during corneal wound repair in high gluose condition.Curr Eye Res, 2000, 21(2): 608- 615.